Veradermics

(NYSE) MANE

Current Price$108.10

Market Cap$4.10B

Since IPO (2026)+204%

5 YearN/A

1 YearN/A

1 Month+90%

Veradermics Financials at a Glance

Market Cap

$4.10B

Revenue (TTM)

$0.00

Net Income (TTM)

$27.51

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1.52 (Low)

Dividend

$0.00

Beta (Volatility)

-1.52 (Low)

Price

$108.10

Volume

592,324

Open

$109.57

Price

$108.10

Volume

592,324

Open

$109.57

Previous Close

$107.85

Daily Range

$106.48 - $112.84

52-Week Range

$17.00 - $117.71

Dividend

$0.00

Beta (Volatility)

-1.52 (Low)

Price

$108.10

Volume

592,324

Open

$109.57

Previous Close

$107.85

Daily Range

$106.48 - $112.84

52-Week Range

$17.00 - $117.71

MANE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veradermics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Reid Waldman, MD

Website

www.veradermics.com

Headquarters

New Haven, CT 06513, US

MANE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-49%

Return on Assets

-45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.10B

Shares Outstanding

37.34M

Volume

592.32K

Avg. Volume

513.52K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$26.78M

EBITDA

$25.90M

Operating Cash Flow

$23.69M

Capital Expenditure

$0.00

Free Cash Flow

$23.69M

Cash & ST Invst.

$53.08M

Total Debt

$0.00

Veradermics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.10B

N/A

Market Cap/Employee

$195.18M

N/A

Employees

N/A

Net Income

$5.66M

N/A

EBITDA

$5.37M

N/A

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$15.12M

N/A

Accounts Receivable

$1.23M

N/A

Inventory

$0.00

N/A

Long Term Debt

$16.00K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-44.61%

N/A

Return on Invested Capital

-48.99%

N/A

Free Cash Flow

$3.63M

N/A

Operating Cash Flow

$3.63M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TVTXTravere Therapeutics, Inc.

TVTXTravere Therapeutics, Inc.$42.66-4.69%

OVIDOvid Therapeutics Inc.

OVIDOvid Therapeutics Inc.$2.73-1.80%

ABEOAbeona Therapeutics Inc.

ABEOAbeona Therapeutics Inc.$5.77-3.99%

HELPCybin Inc. Common Stock

HELPCybin Inc. Common Stock$5.34-3.61%

PLYXPolaryx Therapeutics, Inc. Common Stock

PLYXPolaryx Therapeutics, Inc. Common Stock$3.82+0.53%

LSTALisata Therapeutics, Inc.

LSTALisata Therapeutics, Inc.$3.23-0.92%

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.67-17.85%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

INTCIntel

INTCIntel$109.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

IRENIren

IRENIren$56.85-0.07%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

Questions About MANE

What is the current price of Veradermics?

Veradermics is trading at $107.85 per share.

What is the 52-week range for Veradermics?

Over the past 52 weeks, Veradermics has traded between $17.00 and $117.71.

How much debt does Veradermics have?

As of the most recent reporting period, Veradermics reported total debt of $4,000.

How much cash does Veradermics have on hand?

Veradermics reported $21.77M in cash and cash equivalents in its most recent financial results.

What is Veradermics’s dividend yield?

Veradermics does not currently have a dividend yield.

Veradermics

Veradermics Financials at a Glance

MANE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Veradermics

MANE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Veradermics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MANE

What is the current price of Veradermics?

What is the 52-week range for Veradermics?

How much debt does Veradermics have?

How much cash does Veradermics have on hand?

What is Veradermics’s dividend yield?

Premium Investing Services